Short interest in Eagle Pharmaceuticals Inc (OTC:EGRX) decreased during the last reporting period, falling from 353.26K to 346.66K. This put 4.15% of the company's publicly available shares short.

Short interest for Eagle Pharmaceuticals gives investors a sense of the degree to which investors are betting on the decline of Eagle Pharmaceuticals's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 48.32K shares traded per day, it would take 7.17 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.